Pacira Pharmaceuticals reported $105.77M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acelrx Pharmaceuticals ACRX:US $ 26.33M 8.04M
Adamas Pharmaceuticals ADMS:US 88.8M 36.03M
Aerie Pharmaceuticals AERI:US $ 79.96M 42.74M
Amerisourcebergen ABC:US $ 2553.22M 4087.96M
Astellas Pharma 4503:JP Y 301920M 24208M
Biodelivery Sciences International BDSI:US 119.85M 3.42M
Bristol Myers Squibb BMY:US $ 11024M 42M
Cara Therapeutics CARA:US $ 22.33M 184K
Coherus Biosciences CHRS:US $ 329.74M 70.25M
Depomed DEPO:US $ 54.43M 6.6M
Endo International Ordinary Shares ENDP:US $ 1545.17M 117.4M
Flexion Therapeutics FLXN:US $ 107.63M 8.92M
Heron Therapeutics HRTX:US $ 191.17M 131.43M
Horizon Pharma HZNP:US $ 812.32M 0.71M
Ironwood Pharmaceuticals IRWD:US $ 492.7M 54.23M
Lannett LCI:US $ 93.29M 12M
Ligand Pharmaceuticals LGND:US $ 301.83M 269.98M
Nektar Therapeutics NKTR:US $ 152.34M 2.18M
Omeros OMER:US $ 12.7M 3.67M
Pacira Pharmaceuticals PCRX:US $ 105.77M 39.08M
Perrigo Ordinary Shares PRGO:US $ 317.5M 153.4M
Revance Therapeutics RVNC:US $ 167.63M 81.79M
Supernus Pharmaceuticals SUPN:US $ 223.77M 31.87M
Teva Pharmaceutical TEVA:IT 2.44B 693M
Xeris Pharmaceuticals Inc XERS:US $ 63.6M 3M
Zoetis ZTS:US $ 3657M 57M